Science

 PSYBIO THERAPEUTICS  AND MIAMI UNIVERSITY: 

SOLVING THE CHALLENGE OF CLINICAL SCALE PRODUCTION

Current methods remain tedious and costly

Involving numerous intermediate separation and purification steps resulting in an

the overall yield of 49% from 4-hydroxy indole (Shirota et al., 2003), incurring

an estimated cost of $2000 per gram for pharmaceutical-grade psilocybin

(Fricke et al., 2019).

Platform technology enables rapid generation

Of additional psychoactive compounds with distinct desirable properties.

Utilizing our proprietary platform technology

Our solution is cheaper, faster, cleaner, and greener. Patent-pending

process of using pharmaceutically scalable prokaryotic hosts. Genetic

optimization has resulted in a 32-fold improvement in psilocybin yield.

513-449-9585

Info@PsyBioLife.com

9 Plaza Real S.

Boca Raton, FL 33432